Dyne Therapeutics, Inc. — Form D

Dyne Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-14. The offering totals $115.7M, of which $115.7M was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-08-14
Form: D
Accession: 0001818794-20-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $115.7M
Amount sold: $115.7M
Investors: 19
Date of first sale: 2020-08-07
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-373216

Issuer

Name: Dyne Therapeutics, Inc.
CIK: 0001818794
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 830 WINTER STREET, WALTHAM, MA, 02451
Phone: (781) 786-8230

Officers, directors & promoters (12)

Name	Role	Location
Joshua Brumm	Director	Waltham, MA
Edward Hurwitz	Director	San Diego, CA
Dirk Kersten	Director	Waltham, MA
Lawrence Klein, Ph.D.	Director	Waltham, MA
David Lubner	Director	Gaithersburg, MD
Jason Rhodes	Director	Cambridge, MA
Catherine Stehman-Breen, M.D.	Director	Waltham, MA
Oxana Beskrovnaya, Ph.D.	Executive Officer	Waltham, MA
Joshua Brumm	Executive Officer	Waltham, MA
Jonathan McNeill, M.D.	Executive Officer	Waltham, MA
Richard Scalzo	Executive Officer	Waltham, MA
Romesh Subramanian, Ph.D.	Executive Officer	Waltham, MA

More